Endocyte is a biopharmaceutical company seeking to maximize the potential of small molecule drug conjugates (SMDCs) with companion imaging agents. The goal of the Endocyte process is to identify patients who can benefit from treatment, enabling physicians and patients to make accurate, timely treatment decisions.